Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 15346 | 647 | 21.0 | 67% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 434 | 15650 | CHEMOTHERAPY-TOKYO//JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//CEFEPIME |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CEFEPIME | Author keyword | 38 | 32% | 15% | 98 |
| 2 | CEFPIROME | Author keyword | 18 | 45% | 5% | 30 |
| 3 | FK037 | Author keyword | 8 | 100% | 1% | 5 |
| 4 | CEFEPIME HYDROCHLORIDE | Author keyword | 3 | 60% | 0% | 3 |
| 5 | FOURTH GENERATION CEPHALOSPORIN | Author keyword | 3 | 60% | 0% | 3 |
| 6 | CREPIT | Address | 2 | 67% | 0% | 2 |
| 7 | N METHYLPYRROLIDINE | Author keyword | 2 | 43% | 0% | 3 |
| 8 | A 4TH GENERATION CEPHALOSPORIN | Author keyword | 1 | 100% | 0% | 2 |
| 9 | CEFEPIME DETERMINATION | Author keyword | 1 | 100% | 0% | 2 |
| 10 | CEFEPIME FOR INJECTION | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CEFEPIME | 38 | 32% | 15% | 98 | Search CEFEPIME | Search CEFEPIME |
| 2 | CEFPIROME | 18 | 45% | 5% | 30 | Search CEFPIROME | Search CEFPIROME |
| 3 | FK037 | 8 | 100% | 1% | 5 | Search FK037 | Search FK037 |
| 4 | CEFEPIME HYDROCHLORIDE | 3 | 60% | 0% | 3 | Search CEFEPIME+HYDROCHLORIDE | Search CEFEPIME+HYDROCHLORIDE |
| 5 | FOURTH GENERATION CEPHALOSPORIN | 3 | 60% | 0% | 3 | Search FOURTH+GENERATION+CEPHALOSPORIN | Search FOURTH+GENERATION+CEPHALOSPORIN |
| 6 | N METHYLPYRROLIDINE | 2 | 43% | 0% | 3 | Search N+METHYLPYRROLIDINE | Search N+METHYLPYRROLIDINE |
| 7 | A 4TH GENERATION CEPHALOSPORIN | 1 | 100% | 0% | 2 | Search A+4TH+GENERATION+CEPHALOSPORIN | Search A+4TH+GENERATION+CEPHALOSPORIN |
| 8 | CEFEPIME DETERMINATION | 1 | 100% | 0% | 2 | Search CEFEPIME+DETERMINATION | Search CEFEPIME+DETERMINATION |
| 9 | CEFEPIME FOR INJECTION | 1 | 100% | 0% | 2 | Search CEFEPIME+FOR+INJECTION | Search CEFEPIME+FOR+INJECTION |
| 10 | CEFPIROME SULFATE | 1 | 50% | 0% | 2 | Search CEFPIROME+SULFATE | Search CEFPIROME+SULFATE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BMY 28142 | 127 | 84% | 11% | 69 |
| 2 | HR 810 | 51 | 79% | 5% | 33 |
| 3 | FK 037 | 17 | 100% | 1% | 8 |
| 4 | FK037 | 11 | 78% | 1% | 7 |
| 5 | HR810 | 8 | 75% | 1% | 6 |
| 6 | BROAD SPECTRUM CEPHALOSPORIN | 8 | 19% | 6% | 38 |
| 7 | CEPHALOSPORIN | 8 | 10% | 11% | 70 |
| 8 | CEFPIROME HR 810 | 7 | 67% | 1% | 6 |
| 9 | CEFPIROME | 6 | 28% | 3% | 17 |
| 10 | CEFEPIME | 5 | 13% | 6% | 36 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| CEFEPIME - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE | 1994 | 104 | 112 | 71% |
| Efficacy and safety of cefepime: a systematic review and meta-analysis | 2007 | 85 | 67 | 37% |
| Cefepime: A fourth-generation parenteral cephalosporin | 1996 | 39 | 55 | 82% |
| CEFEPIME - A NEW 4TH-GENERATION CEPHALOSPORIN | 1994 | 43 | 90 | 73% |
| Review of the pharmacokinetics of cefepime in children | 2001 | 15 | 11 | 73% |
| Cefepime: a reappraisal in an era of increasing antimicrobial resistance | 2008 | 24 | 141 | 26% |
| Antibiotic therapy for inducible AmpC beta-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides? | 2012 | 14 | 114 | 15% |
| Cefpirome - A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia | 1997 | 19 | 90 | 68% |
| Cephems: Fifty years of continuous research | 2000 | 10 | 9 | 56% |
| LABORATORY ASSESSMENT OF ANTIBACTERIAL ACTIVITY OF ZWITTERIONIC 7-METHOXYIMINO CEPHALOSPORINS | 1995 | 16 | 46 | 76% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CREPIT | 2 | 67% | 0.3% | 2 |
| 2 | PHARM PHARM TECHNOL | 1 | 33% | 0.3% | 2 |
| 3 | CLIN PHARMACOL ANTI INFECT | 1 | 50% | 0.2% | 1 |
| 4 | FEDERAT ANESTHESIOL INTENS CARE EMERGENCY | 1 | 50% | 0.2% | 1 |
| 5 | INFECT DIS CHEMOTHER Y INTERNAL MED 1 | 1 | 50% | 0.2% | 1 |
| 6 | JHARMAJRI EPIP | 1 | 50% | 0.2% | 1 |
| 7 | OR WAGNER PARTNER | 1 | 50% | 0.2% | 1 |
| 8 | SECT COMMUNITY PEDIAT ADOLESCENT MED | 1 | 50% | 0.2% | 1 |
| 9 | CLIN PHARMACOL ANTIINFECT | 0 | 33% | 0.2% | 1 |
| 10 | HUNTER AREA PATHOL | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000217542 | NAGZ//AMPG//AMPR |
| 2 | 0.0000133123 | BURNS TRAUMA CRIT CARE//MUTANT SELECTION WINDOW//ANTIINFECT DEV |
| 3 | 0.0000127852 | HOIGNES SYNDROME//EEG THRESHOLD//EPILEPTOGENIC ACTIVITY |
| 4 | 0.0000121569 | AS 924//ORAL CEPHALOSPORIN//CEFCAPENE PIVOXIL |
| 5 | 0.0000120775 | CHEMOTHERAPY-TOKYO//JAPANESE JOURNAL OF ANTIBIOTICS//RANCHI VET SCI ANIM HUSB |
| 6 | 0.0000099460 | EXOCHELIN//MYCOBACTIN//SIDEROMYCIN |
| 7 | 0.0000095712 | CEFQUINOME//PORPHYROMONAS LEVII//BOVINE NECROTIC VULVOVAGINITIS |
| 8 | 0.0000073816 | PENICILLINS//CEPHALOSPORINS//AMOXICILLIN |
| 9 | 0.0000071006 | DORIPENEM//ERTAPENEM//MEROPENEM |
| 10 | 0.0000070800 | MED BIOL PHARM//URINE BACTERICIDAL ACTIVITY// |